Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people. - Wikidata - awgldk - TriplyDB

Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people.

Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people.

http://www.wikidata.org/entity/Q41095731

about

How healthy is community-dwelling elderly population? Results from Southern Italy.Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients.Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial Geriatric syndromes are potential determinants of the medication adherence status in prevalent dialysis patients.The support of medication reviews in hospitalised patients using a clinical decision support system.The influence of frailty syndrome on medication adherence among elderly patients with hypertension.Potentially inappropriate medications use in community-based aged patients: a cross-sectional study using 2012 Beers criteria Pharmacist's Comprehensive Geriatric Assessment: Introduction and Evaluation at Elderly Patient Admission An evaluation of medication appropriateness and frailty among residents of aged care homes in Malaysia: A cross-sectional study.Sarcopenia and frailty in older patients with diabetes mellitus.Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population.Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study.Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication.Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France.Pre-Frailty, Frailty, and Multimorbidity: Prevalences and Associated Characteristics from Two French National Surveys.The development of an automated ward independent delirium risk prediction model.Association between polypharmacy and cognitive impairment in an elderly Japanese population residing in an urban community.What is polypharmacy? A systematic review of definitions.Proceedings of the Canadian Frailty Network Summit: Medication Optimization for Frail Older Canadians, Toronto, Monday April 24, 2017.Polypharmacy as a Risk Factor for Clinically Relevant Sarcopenia: Results From the Berlin Aging Study II.Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder Aged ≥75 Years: Analysis of a Japanese Post-Marketing Study.The relationship between Frailty and Polypharmacy in older people: a Systematic Review.The composition of polypharmacy: A register-based study of Swedes aged 75 years and older.Trends in polypharmacy over 12 years and changes in its social gradients in South Korea

P2860

Q36738492-5A7171F2-1B25-4AD5-92A3-BBD125D66DE0 Q36805116-8D139C7C-D766-44D0-A35A-6C5DDDC2A072 Q37007416-02242351-91CF-426B-8B0D-A98A80ABAA43 Q37015932-35DEBAC8-3DBA-46EC-A152-F907391B2506 Q37037498-6313DDFF-729E-4520-AF7C-7FB96BF12D5B Q37496481-B11B943B-CAE9-43D5-BBE9-43D181D36BA7 Q37573115-300F79F3-6CBB-45B9-A61E-30803D123B50 Q37675258-B8F8C1F9-FA32-40E6-86B8-1F0D06E1EDBA Q38600217-593E2B98-44C0-4AB1-A920-A261E0242AB3 Q38707986-BD99D9FB-D25A-4195-8EDB-551938B28A5F Q38732016-A2522AA5-96C7-4ECF-8438-0FC2A6803CAF Q38732283-6565F733-63F5-4B50-A1A9-4FC70DB559E4 Q38766079-BBCF7DB5-605F-441B-B1FC-9E6239EC9C88 Q39017613-F82D2A02-7B8B-4E0C-8518-C59DFC208493 Q39317873-B7DD7F86-C3CD-4F3E-A7E5-25E6A1BAA851 Q39767737-B208DBB9-3A8B-4637-8546-3BE735166655 Q40404771-BEFAA5CF-9DF9-4715-8A9F-AE1CC253D1CB Q42374534-6B1708E5-C24B-4326-BAEF-BEAA265F771A Q47103437-0AF66A85-C613-410A-A237-3F20A8A76943 Q47770687-CB02917F-F6D0-478D-BA84-6AF5BFF90FA9 Q47993403-4CF2F908-15BD-45D9-BF93-A40544016557 Q51735324-9D3E72A2-8BE4-48A3-BF1D-30CD49E39B4F Q51758434-1A3C966F-C680-4C8E-94E4-DDBEA998450B Q57210601-A3B5AE73-A812-4421-AE2F-5AB14D524A78

P2860

Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people.

http://www.wikidata.org/entity/Q41095731

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Polypharmacy and frailty: prev ...... nch sample of 2350 old people.

@en

type

label

Polypharmacy and frailty: prev ...... nch sample of 2350 old people.

@en

prefLabel

Polypharmacy and frailty: prev ...... nch sample of 2350 old people.

@en

P1433

Q41095731-555A0C72-4906-41F2-A936-5CE3EAF2B796

P1476

Q41095731-F35F9236-83F1-4F56-A54E-F964C15E791A

P2093

Q41095731-72FFDEFC-59AC-4B03-A006-301248592CBC

Q41095731-A1C8AA13-BB07-47A5-AC34-8795FEFDDD1D

Q41095731-F70C8041-57FA-47A6-A303-9C2004227E26

P2860

Q41095731-087096A0-50DA-4E06-8AD7-AB1DE8424C4B

Q41095731-0FE010EC-DAC1-45A1-BFA8-A689DA7B8C17

Q41095731-13AFC949-F343-4B52-A99F-7B257ECA4981

Q41095731-213E6E93-7E3C-4812-AAA2-BC5E3ACF3B02

Q41095731-2C02387E-E1C2-42CA-9E15-A072059859D3

Q41095731-319E569E-995C-4983-ABB3-845C48A9FEEA

Q41095731-3B581416-DE15-498E-96FF-D4BAC3A31B86

Q41095731-3BFBF8AE-A298-4378-A0D7-6ED4DFD49252

Q41095731-41FBBBB4-EF5F-48E2-81E9-C3FA9045B93C

Q41095731-45274415-66CD-47A9-936E-AE0A57D93FB7

P304

Q41095731-419C0672-93DA-47B4-9B84-14AE89FADE4F

P31

Q41095731-CCCA5F61-092A-4415-8C3E-D4A81076C92D

P356

Q41095731-0EB9A851-6ED7-4A45-8193-8B7EE26D6058

P433

Q41095731-29985C92-8407-4F0C-B699-C09F5E27E534

P478

Q41095731-BF6FF83D-6C5F-4EE4-91A8-FD0D2257577C

P50

Q41095731-59A8A8D9-49F1-4EAF-B2FA-202D8701CDB4

Q41095731-ED0B8B3C-5CD1-4BE3-BDBF-245954B6786C

P577

Q41095731-BBABC8AB-86C9-4720-804C-AFF31AE32A8F

P698

Q41095731-F2342DFE-9C87-4DC8-B9BB-86BA5A4AD90E

P356

P1433

Pharmacoepidemiology and Drug Safety

P1476

Polypharmacy and frailty: prev ...... nch sample of 2350 old people.

@en

P2093

Jean-Jacques Arvieu

http://www.w3.org/2001/XMLSchema#string

Joël Ankri

http://www.w3.org/2001/XMLSchema#string

Juliette Pinot

http://www.w3.org/2001/XMLSchema#string

P2860

Interventions to improve the appropriate use of polypharmacy for older people

“Mini-mental state”

Frailty in older adults: evidence for a phenotype

Development and validation of a geriatric depression screening scale: a preliminary report

Medication errors in elderly people: contributing factors and future perspectives.

Frailty consensus: a call to action.

Potentially inappropriate prescribing among older people in the United Kingdom.

Frailty in elderly people

Implementing the chronic care model for frail older adults in the Netherlands: study protocol of ACT (frail older adults: care in transition).

Triage of frail elderly with reduced exercise tolerance in primary care (TREE). A clustered randomized diagnostic study.

P304

637-646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.3772

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Marie Robine

P577

2015-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25858336

http://www.w3.org/2001/XMLSchema#string